A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

• Status: Completed
• Trial end date: 2005-02-01
• Target enrollment: 0
• Participant gender: All

Summary

A study of the safety and efficacy of Infliximab (Remicade) versus placebo in subjects with Ankylosing Spondylitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centocor, Inc.
• Collaborator: Centocor BV
• Treatments: Infliximab

Criteria

Inclusion Criteria:

• Have had a diagnosis of definite Akylosing Spondylitis for at least 3 months prior to screening

• Have active disease with spinal pain

• receiving or intolerant to standard anti-inflammatory agents

Exclusion Criteria:

• Have Rheumatoid Arthritis, systemic lupus erythematosus, or other inflammatory rheumatic disease

• Have a documented history of fibromyalgia

• Have total ankylosis